V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011149 | 310004564 | null | null | Curative (C) | 2017-03-05 | 2017-04-28 | NB HRNBL-1 BUMEL MAT | N | N | 310018127 | NOT MATCHED |
| 310011150 | 310004583 | 1.81 | 109.95 | Curative (C) | 2019-02-01 | 2019-05-30 | Brentuximab | N | null | 310018245 | BRENTUXIMAB |
| 310011151 | 310004589 | 1.58 | 13.9 | Curative (C) | null | 2015-08-31 | IVE | N | N | 310018278 | IVE |
| 310011152 | 310010702 | 1.69 | 67.5 | Palliative (P) | 2014-10-25 | 2017-01-27 | CARBOPLATIN + LIPOSOMAL DOX | 02 | N | 310018292 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011153 | 310004595 | 1.64 | 24.9 | Palliative (P) | 2018-04-10 | 2018-04-11 | CISPLATIN + GEMCITABINE | null | null | 310018298 | CISPLATIN + GEMCITABINE |
| 310011154 | 310004601 | 1.62 | 57 | Curative (C) | 2014-12-27 | 2014-12-27 | BEAM | 02 | null | 310018317 | BEAM |
| 310011155 | 310004613 | 1.68 | 74.7 | Not known (9) | 2016-11-29 | 2016-12-07 | LEAM | 02 | N | 310018365 | LEAM |
| 310011156 | 310011252 | 1.5 | 53.3 | Disease modification (D) | null | 2018-06-01 | IVE | N | N | 310018383 | IVE |
| 310011157 | 310011254 | 1.57 | 68.9 | null | 2018-04-16 | 2018-04-20 | Brentuximab Vedotin | N | null | 310018444 | BRENTUXIMAB |
| 310011158 | 310007965 | 1.6 | null | Palliative (P) | 2018-04-28 | 2018-05-09 | Methotrexate intrathecal | N | null | 310018446 | METHOTREXATE INTRATHECAL |
| 310011159 | 310007967 | null | 65.6 | Curative (C) | 2014-03-23 | 2015-04-23 | Cyclophosphamide High Dose | 2 | N | 310018458 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011160 | 310007970 | 1.77 | 78.2 | Palliative (P) | 2014-01-03 | 2014-02-28 | Docetaxel + Gemcitabine (prior RT) | null | N | 310018465 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011161 | 310004635 | 1.78 | null | null | 2013-10-21 | 2013-10-28 | CHOP R - 21 days | 02 | null | 310018467 | CHOP R |
| 310011162 | 310007976 | 1.72 | 83.3 | Curative (C) | 2019-06-04 | 2019-11-17 | CHOP R - 21 days | N | N | 310018478 | CHOP R |
| 310011163 | 310004646 | 1.69 | 68.3 | Curative (C) | 2013-11-05 | 2015-06-03 | CHOP R - 21 days | N | N | 310018484 | CHOP R |
| 310011164 | 310004650 | 1.86 | 68 | Palliative (P) | 2016-07-21 | 2016-07-24 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018504 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011165 | 310004658 | 1.65 | 91.7 | Palliative (P) | 2017-12-02 | 2018-08-21 | CYCLOPHOSPHAMIDE | N | N | 310018510 | CYCLOPHOSPHAMIDE |
| 310011166 | 310004666 | null | 23.6 | Palliative (P) | 2017-05-19 | 2017-05-26 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310018530 | CISPLATIN + RT |
| 310011167 | 310004670 | 1.65 | null | Curative (C) | 2019-04-01 | 2019-07-03 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310018537 | CISPLATIN + RT |
| 310011168 | 310004674 | 1.53 | 55.1 | null | 2019-03-11 | 2019-03-11 | Ipilimumab | N | null | 310018548 | IPILIMUMAB |
| 310011170 | 310004690 | 1.77 | 68 | Palliative (P) | 2016-02-15 | 2016-02-24 | Etoposide oral | 02 | N | 310018590 | ETOPOSIDE |
| 310011171 | 310009771 | 1.85 | 73 | Disease modification (D) | 2019-02-11 | 2018-09-04 | Bexarotene | 2 | N | 310018640 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310011172 | 310008009 | 1.72 | 72 | Palliative (P) | 2014-07-22 | 2014-10-18 | CARBOPLATIN + ETOPOSIDE | N | N | 310018647 | CARBOPLATIN + ETOPOSIDE |
| 310011173 | 310008010 | 1.56 | null | Palliative (P) | 2019-07-14 | 2019-08-11 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | Y | null | 310018650 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011174 | 310004712 | 1.72 | 79.9 | Palliative (P) | 2015-08-03 | 2015-09-26 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | N | 310018651 | CARBOPLATIN + ETOPOSIDE |
| 310011175 | 310004716 | 1.41 | 86.8 | Curative (C) | 2017-06-19 | 2017-06-20 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | 310018680 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011176 | 310004719 | null | 55 | Curative (C) | 2014-09-21 | 2014-09-26 | Docetaxel 100mg/m2 (21 day) | N | N | 310018685 | DOCETAXEL |
| 310011177 | 310008016 | 1.66 | null | Curative (C) | 2014-07-23 | 2014-07-25 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | 310018688 | DOCETAXEL + GEMCITABINE |
| 310011178 | 310004730 | 1.89 | 79.5 | Palliative (P) | 2014-06-08 | 2015-02-11 | Docetaxel+Gemcitabine (no prior RT) | N | N | 310018701 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011179 | 310004739 | 1.85 | null | Palliative (P) | 2016-05-03 | 2016-11-16 | Docetaxel 75mg/m2 (21 day) | 2 | N | 310018723 | DOCETAXEL |
| 310011180 | 310004743 | 1.58 | 79 | Curative (C) | 2018-07-07 | 2018-07-11 | GDP | 2 | N | 310018733 | GDP |
| 310011181 | 310008031 | 1.59 | 74.6 | Palliative (P) | 2016-04-27 | 2016-05-06 | Methotrexate intrathecal | N | N | 310018736 | METHOTREXATE INTRATHECAL |
| 310011182 | 310004749 | 1.76 | 102.4 | Curative (C) | 2018-02-15 | 2018-06-16 | GDP | N | N | 310018744 | GDP |
| 310011183 | 310004757 | 1.55 | 76 | Palliative (P) | 2016-02-17 | 2016-02-17 | Cisplatin 7 day | 02 | N | 310018778 | CISPLATIN |
| 310011184 | 310004769 | null | 66 | Curative (C) | null | 2015-10-24 | Rituximab | null | Y | 310018852 | RITUXIMAB |
| 310011185 | 310004772 | 1.63 | 72.4 | null | 2017-05-19 | 2017-10-06 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | 310018858 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011186 | 310004776 | 1.63 | null | Palliative (P) | 2018-08-31 | 2018-09-30 | Bevacizumab+Carbo+Pacliaxel | N | Y | 310018871 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011187 | 310004782 | 1.89 | null | Curative (C) | 2018-06-06 | 2018-06-16 | Methotrexate intrathecal | N | N | 310018888 | METHOTREXATE INTRATHECAL |
| 310011188 | 310008052 | 1.52 | 92.9 | null | 2016-06-05 | 2016-06-05 | Bexarotene | N | N | 310018896 | UKALL2011 |
| 310011189 | 310004788 | 1.8 | 39.6 | Curative (C) | 2015-11-25 | 2015-11-25 | CHOP R | 02 | N | 310018898 | CHOP R |
| 310011190 | 310008055 | 1.57 | 77.2 | Adjuvant (A) | 2017-06-22 | 2017-06-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310018900 | DOCETAXEL |
| 310011191 | 310004794 | 0 | null | null | 2015-08-22 | 2015-09-05 | Rituximab | Y | Y | 310018919 | RITUXIMAB |
| 310011192 | 310004800 | 1.54 | 96 | Palliative (P) | 2015-09-08 | 2015-10-03 | Docetaxel + Gemcitabine (prior RT) | 02 | Y | 310018942 | DOCETAXEL + GEMCITABINE |
| 310011193 | 310004810 | 1.81 | 67.7 | Not known (9) | 2016-09-24 | 2016-09-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | Y | 310018968 | CARBOPLATIN + ETOPOSIDE |
| 310011194 | 310004817 | null | 69.7 | Curative (C) | null | 2016-01-30 | Cisplatin | N | N | 310018992 | CISPLATIN |
| 310011195 | 310004819 | 1.64 | 82.6 | Curative (C) | 2017-03-28 | 2017-04-10 | Cisplatin | 02 | N | 310018995 | CISPLATIN |
| 310011196 | 310009794 | 1.6 | 79 | Curative (C) | 2015-03-10 | 2015-03-12 | Cyclophosphamide High Dose | 2 | N | 310018998 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011197 | 310004825 | 1.7 | 73.5 | null | 2017-06-05 | 2017-11-21 | Docetaxel | 2 | N | 310019005 | DOCETAXEL |
| 310011198 | 310004832 | 1.93 | 94 | Disease modification (D) | 2018-02-12 | 2018-02-13 | Etoposide oral | N | N | 310019038 | ETOPOSIDE |
| 310011199 | 310004843 | 1.41 | 89 | Disease modification (D) | 2015-03-05 | 2015-03-19 | Ipilimumab | 2 | N | 310019058 | IPILIMUMAB |